1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Autoinjectors Global Market Report 2021: COVID-19 Implications And Growth

Autoinjectors Global Market Report 2021: COVID-19 Implications And Growth

  • September 2021
  • 175 pages
  • ID: 6144646
  • Format: PDF
  • The Business Research Company

Summary

Table of Contents

Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca.

The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth rate (CAGR) of 21.3%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $5.95 billion in 2025 at a CAGR of 19.3%.

The autoinjectors market consists of sales of auto-injectors by entities (organizations, sole traders, and partnerships) that are designed to help people overcome their fear of using a needle-based medication delivery system on their own.An autoinjector is a device for injecting a single, preset dose of medication into one’s own body.

It generally consists of a spring-loaded syringe that is activated when the device is pressed firmly against the body.

The main types of autoinjectors are disposable autoinjectors and reusable autoinjectors.The disposable autoinjectors market consists of sales of disposable autoinjectors by entities (organizations, sole traders, and partnerships) that are designed to replace traditional pre-filled syringes and eliminate psychological barriers by removing the needle from the patient’s view.

Disposable autoinjectors combine a spring-powered power source with a protected needle that administers the required drug solution subcutaneously or intramuscularly.The different therapies include rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, other therapies and are administered in various routes such as subcutaneous, intramuscular.

These are sold to customers through an online retailer and pharmacy and are implemented in various verticals such as home care settings, hospitals and clinics, others.

North America was the largest region in the autoinjectors market in 2020.Asia Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The growing technological advancements are shaping the autoinjectors market.Major players operating in the autoinjectors sector are focused on developing technological solutions for autoinjectors to meet the demand for a viscous biologics delivery mechanism.

For instance, in February 2021, Becton Dickinson (BD), a US-based medical device company is developing Intevia 2.25 mL based on thinner wall cannula technology. The Intevia 2.25 mL is a patient-centric device that works seamlessly with BD Neopak XtraFlow prefillable syringes and has an 8-millimeter needle with a thinner wall.

In March 2020, SHL medical, a Switzerland-based provider of advanced delivery devices, such as autoinjectors, pen injectors, advanced inhalers, and wearable drug delivery systems, acquired Weibel CDS for an undisclosed amount.Through this acquisition, SHL is expected to expand its portfolio of innovative drug delivery solutions for injection devices.

Weibel CDS is a Swiss medical technology company that specializes in the research and development of patch injection systems and devices.

The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years.Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention.

Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world’s top causes of mortality and disability.Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis.

For instance, according to the Imperial College London research in 2020, chronic diseases are expected to kill almost 41 million people globally each year, accounting for seven out of ten fatalities.Around 17 million of these fatalities are classified as premature, with people dying substantially younger than predicted on average.

Therefore, the increasing prevalence of chronic diseases drives the growth of the autoinjectors market.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 5000
  • September 2021
  • 175 pages

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO) market ...

  • World
  • Europe
  • Chronic Disease
  • Biopharmaceutical
  • Industry analysis

Surgical Simulation Market $ 4900 August 2021


ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on